trump executive order on glp 1 unveils deal to expand coverage and lower costs obesity drugs Pres. Donald Trump announced that

These include conditions such as gastroparesis, diverticulosis, gastritis, abdominal pain, nausea, as well as issues like hypotension, syncope, sleep disturbances and interstitial nephritis

: ( ),

There are side effects that may occur from GLP-1 medications, including possible serious risks if dosages are not correctly administered, but most side effects include dehydration and stomach issues, like nausea, diarrhea or constipation

But heres my perspective

(A declining obesity rate would expect to stabilize, but not reduce, the percentage of adults who have been diagnosed with diabetes.) Gallup calculates obesity using the federal standard of having a BMI of 30 or higher, while the diabetes rate includes both those with Type 1 and Type 2 diabetes

different recombinant proteins were determined using a BIACORE TM T200 from Cytiva